Eye-tracking test could facilitate earlier Alzheimer's diagnoses

September 18, 2012 in Alzheimer's disease & dementia

With the steady increase in the life expectancy of Europe's population, researchers estimate that the number of people affected by age-related diseases, such as Alzheimer's disease, will increase dramatically in the next few years. This makes improving our understanding of the disease and its early diagnosis an important priority. New research, led by Lancaster University in the United Kingdom, in partnership with Royal Preston Hospital, Lancashire Teaching Hospitals NHS foundation trust, and published in the Journal of the American Aging Association, shows that people with Alzheimer's disease have difficulty with one particular type of eye-tracking test.

That a simple eye-tracking test could hold the key to earlier Alzheimer's diagnosis is an important finding, according to Dr Trevor Crawford from the Department of Psychology and the Centre for Ageing Research, Lancaster University. He noted that these new results were potentially very exciting as they demonstrated, for the first time, a connection with the that is so often the first noticeable symptom in Alzheimer's disease.

'The diagnosis of Alzheimer's disease is currently heavily dependent on the results of a series of lengthy ,' Dr Crawford said. 'However, patients with a often find that these tests are difficult to complete due to a lack of clear understanding and lapse in their attention or motivation.

'Over the last 10 years researchers in laboratories around the world have been working on an alternative approach based on the brain's control of the movements of the eye as a tool for investigating such as attention, cognitive and memory.'

In the study, 18 patients with Alzheimer's disease, 25 patients with Parkinson's disease, 17 healthy young people and 18 healthy older people were asked to follow the movements of light on a , and in some instances they were asked to look the opposite way, away from the light.

What the research group found were stark contrasts in the eye-tracking measurements taken from the research sample. In particular, patients with Alzheimer's made mistakes on the task where they were asked to look away from the light and were unable correct those errors, despite the fact that they were able to respond perfectly normally when they were asked to look towards the light. These uncorrected errors were 10 times more frequent in the Alzheimer's patients compared to the control groups.

Researchers also measured memory function among those Alzheimer's patients who found the test difficult and were able to show a clear correlation with lower memory function.

'This study takes this work forward because we found strong evidence that the difficulty in noticing and correcting the errors was probably caused by a problem in the memory networks of the brain that allow us to store the spatial position of objects in the environment,' Dr Crawford explained. 'The light tracking test could play a vital role in diagnosis as it allows us to identify, and exclude number alternative explanations of the test results.'

More information: Crawford, T.J., et al. The role of working memory and attentional disengagement on inhibitory control: effects of aging and Alzheimer's disease'. AGE, 2012.

Journal reference: AGE search and more info website

Provided by CORDIS search and more info website

4 /5 (1 vote)  

Rank 4 /5 (1 vote)
Relevant PhysicsForums posts

More news stories

Drugs found to both prevent and treat Alzheimer's disease in mice

Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.

Alzheimer's disease & dementia created 12 hours ago | popularity 5 / 5 (6) | comments 0 | with audio podcast

Scientists identify molecular trigger for Alzheimer's disease

Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons ...

Alzheimer's disease & dementia created May 20, 2013 | popularity 5 / 5 (4) | comments 0 | with audio podcast

Study finds that sleep apnea and Alzheimer's are linked

A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.

Alzheimer's disease & dementia created May 19, 2013 | popularity 5 / 5 (3) | comments 0 | with audio podcast

Alzheimer's leaves bilingual victims stranded in Canada

The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.

Alzheimer's disease & dementia created May 19, 2013 | popularity not rated yet | comments 0

Study identifies new approach to improving treatment for MS and other conditions

(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...

Alzheimer's disease & dementia created May 17, 2013 | popularity 5 / 5 (2) | comments 0 | with audio podcast


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.